|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
8 June 2015 |
|
Main ID: |
NCT02213120 |
|
Date of registration:
|
08/08/2014 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
To Study the Characteristics of Different Types of Vertigo in Patients Attending the Ear Nose & Throat (ENT) Clinics.
VERTIGO |
|
Scientific title:
|
To Study the Characteristics of Different Types of Vertigo in Patients Attending the ENT Clinics. |
|
Date of first enrolment:
|
August 2014 |
|
Target sample size:
|
400 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT02213120 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Pakistan
| | | | | | | |
|
Contacts
|
|
Name:
|
Raeefuddin Ahmed, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Abbott |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Male or female patients 18 years of age and older
- Patients with vestibular vertigo of known or unknown origin
- Patients who are willing and able to provide written informed consent
Exclusion Criteria:
- Patients with any condition which, in the opinion of the investigator, makes the
patient unsuitable for inclusion based on clinical judgment
- Patient with psychiatric disorders, significant neurological disorder or spinal cord
damage that would make the evaluation difficult for the investigator
- Patients who are not willing to give informed consent
- Patients with a known history of hypersensitivity to betahistine
- Patients with a history of pheochromocytoma
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Vertigo
|
|
Primary Outcome(s)
|
|
Characteristics (Different Types) of dizziness
[Time Frame: 6 months]
|
|
Secondary Outcome(s)
|
|
Quality of Life (QoL) of patients at baselines
[Time Frame: 6 months]
|
|
QoL of patients post treatment
[Time Frame: 6 months]
|
|
Management of vertigo currently in practice
[Time Frame: 6 months]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|